Great news! After I sent you the e-Alert "Hot Buttons" (1/17/07) concerning the use of intravenous ascorbic acid (IAA) in the treatment of cancer I came across a very encouraging report. According to the Chicago Tribune, the FDA has given Cancer Treatment Centers of America (CTCA) approval to launch an IAA trial. Christopher Lis, CTCA's vice president of research and development, told the Tribune that the trial's first phase will be limited to 18 cancer patients who have used conventional treatments without success. Researchers will attempt to establish an optimal therapeutic dose. The Tribune also interviewed Jeffrey Blumberg, a Tufts University professor of nutrition, who noted that IAA might reduce chemotherapy side effects. This comment reminded me of a posting I found in the HSI Healthier Talk community forums. An HSI member named Donna wrote: "My best friend has been on the chemo routine for cancer (non-Hodgkin's lymphoma), she has had 5 chemos every 6 weeks. She is also getting 50 grams of vitamin C intravenously three times a week. She has had no side effects from either, in fact she goes shopping after the chemo, and leads a normal life. "During the Christmas holidays she discovered that it's the vitamin C that is preventing side effects from the chemo, as she wasn't able to get the treatments. After 7 days without C she was in pain all over & had sores inside her mouth. When she went back after 10 days for a treatment of vitamin C she was feeling much better just during the drip of C. The next day she was completely fine again." You can be sure I'll be keeping an eye out for the results of the CTCA trial. | 
